Search Results for Editorial

Showing 1 – 6

Nutrition, Health and Disease Management, Advertising, Promotion, Labeling and a Preview of November's MDR, IVDR Update By Gloria Hall - Published 07 November 2017

Feature articles over the past several weeks covered two main themes: nutrition, health and disease management and advertising, promotion, labeling.

Categories: Features, Advertising and Promotion, Labeling, Nutritional and dietary supplements

Tags: Regulatory Focus, Feature Articles, Editorial

Global Reimbursement Strategy, Advertising, Labeling and Marketing, and a Preview of Health Related Foods By Gloria Hall - Published 04 October 2017

The following is a summary of feature articles posted over the past weeks with links and a preview of what's to come in October.

Categories: Features, Canada, Europe, US, FDA, Health Canada, MHRA, NICE, Advertising and Promotion, Labeling, Nutritional and dietary supplements, Reimbursement

Tags: Regulatory Focus, Feature Articles, Editorial

Health Technology Assessment, Reimbursement, Scientific Research, Risk Management, Generic Drug Legislation and a Preview of September By Gloria Hall - Published 06 September 2017

The following is a summary of feature articles posted over the past weeks with links and a preview of what's to come in September.

Categories: Features, FDA, Health Canada, Biologics and biotechnology, Generic drugs, Medical Devices, Regulatory strategy, Reimbursement

Tags: Regulatory Focus, Feature Articles, Editorial

Op-ed: New RAPS Research on the Regulatory Profession By Sherry Keramidas, Executive Director – RAPS, PhD, FASAE, CAE - Published 25 July 2012

Categories: RAPS

Tags: Opinion, Scope of Practice, Editorial, Survey, Latest News, compensation, career, regulatory

NEJM Editorial Calls for Tougher Regulation of Dietary Supplements By Alexander Gaffney - Published 27 January 2012

Categories: FDA

Tags: Pieter Cohen, NEJM, Supplements, DSHEA, Daniel Fabricant, NDI, Editorial, Latest News

Lancet: US FDAs Approach to Silicone-Gel Regulation a Model for Others By Alexander Gaffney - Published 17 January 2012

Categories: FDA

Tags: Editorial, The Lancet, Breast Implant, PIP, Latest News, regulatory